Your browser doesn't support javascript.
loading
Overcoming inter-observer planning variability in target volume contouring and dose planning for high-risk neuroblastoma - a European multicenter effort of the SIOPEN radiotherapy committee.
Jazmati, Danny; Brualla, Lorenzo; Littooij, Annemieke S; Webber, Britta; Dieckmann, Karin; Janssens, Geert O; Simon, Thorsten; Gaze, Mark N; Merta, Julien; Serrano, Antonio; Dietzsch, Stefan; Kramer, Paul-Heinz; Wulff, Jörg; Boterberg, Tom; Timmermann, Beate.
Afiliação
  • Jazmati D; Department of Particle Therapy, University Hospital Essen, Germany; West German Proton Therapy Centre Essen (WPE), Germany; West German Cancer Center (WTZ), Germany. Electronic address: danny.jazmati@uk-essen.de.
  • Brualla L; West German Proton Therapy Centre Essen (WPE), Germany; West German Cancer Center (WTZ), Germany; Faculty of Medicine, University of Duisburg-Essen, Germany.
  • Littooij AS; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., the Netherlands; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: alittooij@hotmail.com.
  • Webber B; Danish Centre of Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • Dieckmann K; Department of Radio-Oncology, Medical University of Vienna, Vienna, Austria.
  • Janssens GO; Department of Radiation Oncology, University Medical Center Utrecht, and Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Simon T; Pediatric Oncology and Hematology, University of Cologne, Cologne, Germany.
  • Gaze MN; Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Merta J; Department of Particle Therapy, University Hospital Essen, Germany; West German Proton Therapy Centre Essen (WPE), Germany.
  • Serrano A; Faculty of Engineering, University of Mondragon, Spain.
  • Dietzsch S; Department of Radiation Oncology, University Hospital Leipzig, Leipzig, Germany.
  • Kramer PH; West German Proton Therapy Centre Essen (WPE), Germany; West German Cancer Center (WTZ), Germany.
  • Wulff J; West German Proton Therapy Centre Essen (WPE), Germany; West German Cancer Center (WTZ), Germany.
  • Boterberg T; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.
  • Timmermann B; Department of Particle Therapy, University Hospital Essen, Germany; West German Proton Therapy Centre Essen (WPE), Germany; West German Cancer Center (WTZ), Germany; German Cancer Consortium (DKTK), Germany.
Radiother Oncol ; 181: 109464, 2023 04.
Article em En | MEDLINE | ID: mdl-36640946

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia (Especialidade) / Neuroblastoma Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia (Especialidade) / Neuroblastoma Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article